Rotigotine - Restless Leg Syndrome
You are here : Home > Formulary Search > Rotigotine - Restless Leg Syndrome
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Patches
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
Patients with severe symptoms, who are obese, co-morbid depression, increased risk of falls or cognitive impairment. Consider use of patch if significant daytime symptoms as it has a long duration of action.
Documentation
Evidence Review
PAD Profile
ChemicalSubstance :
Rotigotine
Indication :
Restless Leg Syndrome
Group Name :
Keywords :
dopamine receptor agonists
Brand Names Include :
Neupro
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Committee Recommendations (1)
Rotigotine is recommended as a FIRST line option for the treatment of Restless Leg Syndrome, as per CKS guidance.
Link to CKS page - https://cks.nice.org.uk/restless-legs-syndrome
Other Indications
Below are listed other indications that Rotigotine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Restless Leg Syndrome.